Searched for
CLINICAL TRIALS NETWORK INDIA
Lord’s Mark secures MHRA registration for dialysis device, plans UK expansionLord's Mark Industries Limited has successfully secured regulatory registration from the MHRA for its innovative haemodialysis machine, pav...- India prominent market for Canon; plans to expand retail network by 2027: India CEO NomuraCanon India has ambitious plans to grow by reaching over 10,000 active resellers by 2027. The company anticipates growing demand in smaller...
- Not expensive skincare or supplements: Harvard-trained gut doctor shares 6 anti-ageing habits he wished he knew at 22Harvard-trained gut doctor Dr Saurabh Sethi highlights the significance of adopting proactive lifestyle habits to avert health complication...
- Ashwagandha’s 24-week safety test brings reassuring findings: ReportA clinical trial involving 1,200 adults evaluated the safety of standardised ashwagandha root extract. Participants took either ashwagandha...
- Motilal Oswal sees Aster DM EBITDA rising 25% CAGR through FY28; sets Rs 910 targetMotilal Oswal has initiated coverage on Aster DM Quality Care with a Buy rating and Rs 910 target, citing merger synergies, capacity expans...
- The trialOne ordinary morning, Josef K. discovers his breakfast is mysteriously missing. As he waits, he becomes increasingly unsettled by the odd b...
- India’s healthcare AI opportunity could become the next big investment storyThe digital rails are ready. India now needs patient capital and founders ambitious enough to build on them.
- Govt, private hospitals likely to be graded on quality & safetyNiti Aayog is developing a national quality framework for public and private hospitals, aligned with international standards, to help patie...
- Rs 78,400 vs Rs 7,750 medicine: Novartis, Eli Lilly oppose bid to cut breast cancer drug prices in IndiaNovartis and Eli Lilly have opposed a Kerala High Court petition seeking government intervention to make two breast cancer drugs cheaper, d...
- Meta misled consumers in case over Cambridge Analytica scandal, New Mexico jury saysThe verdict followed a two-week trial over a lawsuit filed by New Mexico's attorney general in 2021, three years after news reports reveale...
- Lord’s Mark advances AI breast cancer screening towards clinical trialsIn a groundbreaking collaboration with C-MET, Lord's Mark Industries Limited is making strides in breast cancer screening technology. Utili...
- AI-based drug developer Basecamp valued at $800 million after $140 million funding roundThe oversubscribed round was led by S32, with participation from Nvidia, Anthropic's Anthology Fund, Catalio Capital Management, the NATO I...
- India's new drone killer: DRDO starts production process of a mobile weapon that can destroy drone swarms 5 km awayIndia is preparing to move its indigenous 30kW-class laser weapon towards production. DRDO plans to seek an industry partner for the truck-...
- Celldex shares slip 15% as safety concerns cloud skin drug trial win(Rewrites throughout to add company comments, adds shares in paragraph 2, analyst comment in paragraph 5)- Celldex Therapeutics said on Tue...
- Millions take calcium and vitamin D to protect their bones. The biggest review yet suggests the daily pills may not prevent the falls they fear mostA large analysis of 69 trials found little benefit from supplements. Calcium and vitamin D do not significantly prevent fractures or falls....
- Government to ease BA-BE study norms for domestic generic drug approvals, cut import licence timelinesPharmaceutical companies will soon find it easier to conduct drug studies. Applicants can start eligible trials after intimating the drug r...
- Health ministry issues advisory against unregulated stem cell therapies, restricts autism treatment to approved clinical trialsThe Union health ministry issued an advisory against unregulated stem cell therapies. Therapeutic use of stem cells for autism is restricte...
- Health Ministry issues advisory clamping down on unregulated use of stem cell therapiesThe Union Health Ministry has tightened oversight of stem cell therapies, warning against their unregulated use and making clear that they ...
- Agonisingly slow clinical trial is stopping Indian pharma become global innovator from supplierIndia's regulatory hurdles slow down early-stage drug trials significantly. This complexity causes Indian companies to conduct crucial firs...
- Manipal Hospitals scouts for acquisitions in Andhra, Keralam, Delhi-NCR; bets on AI-led healthcareManipal Health Enterprises plans significant expansion across several Indian states. The company is adopting a digital-physical healthcare ...
Load More
